U.S. Health Agencies Call for Pause in J&J COVID Vaccine After 6 People Develop Clots

TUESDAY, April 13, 2021 — After six people who received the Johnson & Johnson one-dose COVID-19 vaccine developed a type of rare and severe blood clot, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention on…
Source: Topamax